Results 161 to 170 of about 50,416 (260)
Impact of Food and Beverage on Enlicitide Pharmacokinetics and LDL‐C Lowering
Enlicitide decanoate is a macrocyclic peptide first‐in‐class oral PCSK9 inhibitor that lowers LDL‐C, with maximal efficacy achieved when administered on an empty stomach. This work characterizes the effects of food, pre‐dose fasting duration (2–8 hours), water volume, common beverages (black coffee and plain tea), and other real‐world scenarios on ...
Douglas G. Johns +22 more
wiley +1 more source
Advancing Precision Therapeutics in Older Adults: A Scoping Review of Pharmacogenomic Service Models
Older adults remain a therapeutically understudied population despite experiencing the highest burden of polypharmacy, age‐related pharmacokinetic and pharmacodynamic variability, and medication‐related harm. Pharmacogenomic testing offers an opportunity to individualize drug therapy in this population; however, its clinical implementation is ...
Eman Wehbe +5 more
wiley +1 more source
Abstract Neural crest cells are multipotent, migratory stem‐like cells essential for vertebrate development that contribute broadly to many tissues including the craniofacial skeleton, peripheral nervous system, and pigment‐producing cells. Their development progresses through phases of induction, specification, delamination, migration, and ...
Allison E. Mancini +2 more
wiley +1 more source
Statins and risk of breast cancer recurrence
Minas Sakellakis,1 Karolina Akinosoglou,1 Anastasia Kostaki,2 Despina Spyropoulou,1 Angelos Koutras,1 1Department of Medicine, Division of Oncology, University Hospital, Patras Medical School, Patras, 2Department of Statistics, Athens University of ...
Akinosoglou K +4 more
core
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen +4 more
wiley +1 more source
Clinical efficacy and safety of statins in managing cardiovascular risk
Navin K Kapur1, Kiran Musunuru21Division of Cardiology, Tufts University – New England Medical Center; Boston, MA, USA; 2Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: Since their introduction in ...
Navin K Kapur, Kiran Musunuru
core
Abstract Aims Natriuretic peptide‐based pre‐heart failure screening has been proposed in recent guidelines. However, an effective strategy to identify screening targets from the general population, more than half of which are at risk for heart failure or pre‐heart failure, has not been well established.
Yuichiro Mori +5 more
wiley +1 more source
Optimal Timing of Statin Initiation for Patients with Type 2 Diabetes
HMG Co-A reductase inhibitors (statins) are an important part of the treatment plan for patients with type 2 diabetes. However, the optimal time to initiate treatment is influenced by many factors. We investigate two such factors in this thesis: (1) the
Mason, Jennifer Elizabeth
core
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi +10 more
wiley +1 more source

